Artificial Intelligence Chatbots and Their Responses to Most Searched Spanish Cancer Questions [0.03%]
人工智能聊天机器人对西班牙语最常搜索的癌症问题的回答
En Cheng,Jesus D Anampa,Carolina Bernabe-Ramirez et al.
En Cheng et al.
Background: Artificial intelligence (AI) chatbots perform well in answering English cancer questions. For Spanish, their performance is unknown and may differ by free vs. paywall versions. ...
A Novel Nomogram to Predict Pathological Complete Response in Breast Cancer Patients and Identify Candidates Who Might Omit Surgery: A Large Cohort Study [0.03%]
一项预测乳腺癌患者病理完全缓解的列线图和识别潜在手术免切患者的大型队列研究
Kaining Ye,Xuehong Liao,Weiping Yang et al.
Kaining Ye et al.
Purpose: To establish and validate a nomogram for predicting pathological complete response (pCR) after neoadjuvant therapy (NAT) in breast cancer (BC) patients, aiming to identify subgroups potentially suitable for non-s...
Cervical Adenocarcinoma: What's Special About the Long-Term Reproductive and Oncological Outcomes of Fertility-Sparing Radical Trachelectomy in It? [0.03%]
保留生育功能的广泛性宫颈切除术治疗宫颈腺癌的长期生殖和肿瘤结局及其特殊性分析
Jingwen Gan,Dongyan Cao,Huimei Zhou et al.
Jingwen Gan et al.
Objective: To present reproductive and oncological outcomes of radical trachelectomy (RT) in patients with cervical adenocarcinomas (AC). Methods: ...
The Biological and Prognostic Implications of the Nicotinic Acetylcholine Receptor α3, α5, and α7 Subunits in Oral Squamous Cell Carcinoma [0.03%]
口腔鳞状细胞癌中乙酰胆碱受体α3、α5和α7亚基的生物学及预后意义
Chi-Maw Lin,Long-Wei Lin,Tseng-Cheng Chen et al.
Chi-Maw Lin et al.
Background: The divergent loop structures of nicotinic acetylcholine receptor (nAChR) α3, α5, and α7 subunits (encoded by CHRNA3, CHRNA5, and CHRNA7) are involved in kinase phosphorylation and signal transduction, pote...
A Real-World Pharmacovigilance Study of Fruquintinib Based on the FDA Adverse Event Reporting System (FAERS) Database [0.03%]
基于美国食品药品监督管理局不良事件报告系统数据库的呋喹替尼真实世界药物警戒研究
Yajing Xu,Dongchen Wang,Yuyan Xu
Yajing Xu
Background: Fruquintinib is a highly selective small-molecule inhibitor that targets vascular endothelial growth factor receptors and is approved for the treatment of metastatic colorectal cancer. Given its increasing cli...
Recent Advancements in Known and Emerging Risk Factors of Hepatocellular Carcinoma [0.03%]
近年来肝细胞癌已知和新兴风险因素的研究进展
Muhammad Masroor Hussain,Bi Feng,Ju-Mei Wang et al.
Muhammad Masroor Hussain et al.
Background: Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and a leading cause of cancer-related deaths worldwide. Despite advancements in antiviral therapies for hepatitis B (HBV) and hepatiti...
The Epidemiology of Neuroendocrine Carcinomas in Taiwan: A Population-Based Cancer Registry Study [0.03%]
台湾神经内分泌癌流行病学特征分析：基于癌症登记数据的研究
Yi-Hsin Yang,Ru-Yu Huang,Pei-Yi Chu et al.
Yi-Hsin Yang et al.
Background: Lung and small cell neuroendocrine carcinomas (SCCs) are the most common sites and histological types of high-grade neuroendocrine carcinoma (NEC). Comprehensive epidemiological information on NECs is limited....
Low Income Has a Negative Effect on Survival Following Diagnosis of Metastatic Colorectal Cancer-A Population-Based Cohort Study [0.03%]
低收入对结直肠癌转移生存率的负面影响--基于人口的队列研究
Malin Ljunggren,Caroline E Dietrich,Cecilia Merk et al.
Malin Ljunggren et al.
Background: Treatment for metastatic colorectal cancer (mCRC) has seen great advances but may not be equally available for all patients. Aim: ...
Incidence, Clinical Features, and Prognostic Value of New-Onset Renal Impairment in Multiple Myeloma [0.03%]
多发性骨髓瘤新发肾损害的发病、临床特征及预后价值
Xiang Liu,Qian Hu,Yuhuan Zheng et al.
Xiang Liu et al.
Background: Previous studies mainly focused on renal impairment (RI) at multiple myeloma (MM) diagnosis, with few investigating new-onset RI post-MM diagnosis. This study aims to indicate the incidence, clinical character...
Multicenter Study
Cancer medicine. 2025 Nov;14(21):e71361. DOI:10.1002/cam4.71361 2025
Characterizing Cancer-Related Cognitive Impairment Among Adolescent and Young Adult Cancer Survivors: Comparison to Individuals Without Cancer [0.03%]
癌症幸存者认知功能损伤的特征研究——与无癌症人群进行对比的青少年及年轻成人癌症患者
Brent J Small,Damon Reed,Danielle Tometich et al.
Brent J Small et al.
Background: Cancer-related cognitive impairment (CRCI) has received little attention among adolescent and young adult (AYA; 18-39 years of age) cancer survivors. The goal of this study was to evaluate differences in objec...